M&A Deal Summary |
|
|---|---|
| Date | 2009-09-03 |
| Target | Sunovion Pharmaceuticals. |
| Sector | Life Science |
| Buyer(s) | Sumitomo Pharma |
| Deal Type | Add-on Acquisition |
| Deal Value | 2.6B USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1897 |
| Sector | Life Science |
| Employees | 3,832 |
| Revenue | 398.8B JPY (2025) |
Sumitomo Pharma is a pharmaceutical and life science company. Sumitomo Pharma was founded in 1897 and is based in Osaka, Japan.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2009 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-12-26 |
Sumitomo Pharma AH
Osaka, Japan Sumitomo Pharma AH is a Japanese animal health company that leverages its advanced product development capabilities accumulated as a subsidiary of a pharmaceutical manufacturer to develop, manufacture, and sell veterinary medicines for companion animals and livestock, especially in Japan. Sumitomo Pharma AH is based in Osaka, Japan. |
Sell | - |